Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Friedrich

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Angewandte Chemie (International Ed. in English)|April 26, 2016
From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo DesignLukas Friedrich, Tiago Rodrigues, Claudia S Neuhaus, et al.
Journal of Chemical Information and Modeling|December 22, 2023
AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS PlatformAndrew Rusinko, Mohammad Rezaei, Lukas Friedrich, et al.
Molecular Informatics|September 22, 2016
Matrix-based Molecular Descriptors for Prospective Virtual Compound ScreeningFrancesca Grisoni, Daniel Reker, Petra Schneider, et al.
Chemmedchem|March 13, 2020
Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A MimeticsLukas Friedrich, Ryan Byrne, Aaron Treder, et al.
Chemmedchem|June 5, 2023
Metabolism of (R)-Praziquantel versus the Activation of a Parasite Transient Receptor Potential Melastatin Ion ChannelLukas Friedrich, Sang-Kyu Park, Peter Ballard, et al.
Science Translational Medicine|December 22, 2021
Mechanism of praziquantel action at a parasitic flatworm ion channelSang-Kyu Park, Lukas Friedrich, Nawal A Yahya, et al.
Neuro-Oncology Advances|July 6, 2026
AI-based selection of tumor regions for genomic profiling in neuropathologyNarmin Ghaffari Laleh, Lukas Friedrich, Fuat Kaan Aras, et al.
Frontiers in Molecular Biosciences|October 16, 2023
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of <i>de novo</i> humanized and sequence-optimized single domain antibodies: a prospective case studyPaul Arras, Han Byul Yoo, Lukas Pekar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo DesignLukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Nature Communications|August 25, 2023
Propensity of selecting mutant parasites for the antimalarial drug cabamiquineEva Stadler, Mohamed Maiga, Lukas Friedrich, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|April 26, 2016
From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo DesignLukas Friedrich, Tiago Rodrigues, Claudia S Neuhaus, et al.
Journal of Chemical Information and Modeling|December 22, 2023
AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS PlatformAndrew Rusinko, Mohammad Rezaei, Lukas Friedrich, et al.
Molecular Informatics|September 22, 2016
Matrix-based Molecular Descriptors for Prospective Virtual Compound ScreeningFrancesca Grisoni, Daniel Reker, Petra Schneider, et al.
Chemmedchem|March 13, 2020
Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A MimeticsLukas Friedrich, Ryan Byrne, Aaron Treder, et al.
Chemmedchem|June 5, 2023
Metabolism of (R)-Praziquantel versus the Activation of a Parasite Transient Receptor Potential Melastatin Ion ChannelLukas Friedrich, Sang-Kyu Park, Peter Ballard, et al.
Science Translational Medicine|December 22, 2021
Mechanism of praziquantel action at a parasitic flatworm ion channelSang-Kyu Park, Lukas Friedrich, Nawal A Yahya, et al.
Neuro-Oncology Advances|July 6, 2026
AI-based selection of tumor regions for genomic profiling in neuropathologyNarmin Ghaffari Laleh, Lukas Friedrich, Fuat Kaan Aras, et al.
Frontiers in Molecular Biosciences|October 16, 2023
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of <i>de novo</i> humanized and sequence-optimized single domain antibodies: a prospective case studyPaul Arras, Han Byul Yoo, Lukas Pekar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo DesignLukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Nature Communications|August 25, 2023
Propensity of selecting mutant parasites for the antimalarial drug cabamiquineEva Stadler, Mohamed Maiga, Lukas Friedrich, et al.
Pageof 3